TG Therapeutics (TGTX) News Today $32.20 +1.25 (+4.04%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period TG Therapeutics, Inc. (NASDAQ:TGTX) Receives Consensus Rating of "Moderate Buy" from AnalystsShares of TG Therapeutics, Inc. (NASDAQ:TGTX - Get Free Report) have earned a consensus rating of "Moderate Buy" from the six analysts that are covering the firm, MarketBeat reports. One research analyst has rated the stock with a hold recommendation and five have assigned a buy recommendation toDecember 20 at 3:02 AM | marketbeat.com19,900 Shares in TG Therapeutics, Inc. (NASDAQ:TGTX) Acquired by Synovus Financial CorpSynovus Financial Corp acquired a new stake in shares of TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) in the 3rd quarter, according to its most recent 13F filing with the SEC. The fund acquired 19,900 shares of the biopharmaceutical company's stock, valued at approximately $465,000. Other instDecember 19 at 5:14 AM | marketbeat.comTeachers Retirement System of The State of Kentucky Buys New Stake in TG Therapeutics, Inc. (NASDAQ:TGTX)Teachers Retirement System of The State of Kentucky purchased a new position in shares of TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 44,450 shares of the biopharmaceuDecember 19 at 4:38 AM | marketbeat.comTG Therapeutics, Inc. (NASDAQ:TGTX) Stock Holdings Lifted by Barclays PLCBarclays PLC lifted its position in TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) by 83.9% in the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 347,057 shares of the biopharmaceutical company's stock after acquiring an additionalDecember 18 at 4:16 AM | marketbeat.comExome Asset Management LLC Has $4.86 Million Stock Holdings in TG Therapeutics, Inc. (NASDAQ:TGTX)Exome Asset Management LLC decreased its position in TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) by 17.5% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 207,627 shares of the biophDecember 14, 2024 | marketbeat.comTG Therapeutics (NASDAQ:TGTX) Rating Increased to Hold at StockNews.comDecember 14, 2024 | americanbankingnews.comTG Therapeutics (NASDAQ:TGTX) Upgraded by StockNews.com to Hold RatingStockNews.com upgraded shares of TG Therapeutics from a "sell" rating to a "hold" rating in a report on Saturday.December 14, 2024 | marketbeat.comState Street Corp Raises Stock Position in TG Therapeutics, Inc. (NASDAQ:TGTX)State Street Corp lifted its position in shares of TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) by 35.8% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 9,094,158 shares of the biopharmaceutical coDecember 12, 2024 | marketbeat.comNeo Ivy Capital Management Buys New Shares in TG Therapeutics, Inc. (NASDAQ:TGTX)Neo Ivy Capital Management bought a new stake in shares of TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 100,780 shares of the biopharmaceutical company'sDecember 11, 2024 | marketbeat.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Trims Holdings in TG Therapeutics, Inc. (NASDAQ:TGTX)UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC cut its stake in TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) by 8.7% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 293,927 shares of the biopharmaDecember 10, 2024 | marketbeat.comFmr LLC Decreases Holdings in TG Therapeutics, Inc. (NASDAQ:TGTX)Fmr LLC trimmed its holdings in shares of TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) by 2.6% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,184,158 shares of the biopharmaceutical company's stDecember 10, 2024 | marketbeat.comCastleark Management LLC Purchases Shares of 168,810 TG Therapeutics, Inc. (NASDAQ:TGTX)Castleark Management LLC acquired a new stake in shares of TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) in the third quarter, according to the company in its most recent filing with the SEC. The firm acquired 168,810 shares of the biopharmaceutical company's stock, valued at approximately $3,9December 8, 2024 | marketbeat.comTG Therapeutics (NASDAQ:TGTX) Rating Lowered to "Sell" at StockNews.comStockNews.com lowered shares of TG Therapeutics from a "hold" rating to a "sell" rating in a research report on Friday.December 6, 2024 | marketbeat.comTG Therapeutics, Inc. (NASDAQ:TGTX) Shares Sold by BNP Paribas Financial MarketsBNP Paribas Financial Markets lowered its stake in shares of TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) by 17.3% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 117,985 shares of tDecember 6, 2024 | marketbeat.comParkman Healthcare Partners LLC Decreases Stake in TG Therapeutics, Inc. (NASDAQ:TGTX)Parkman Healthcare Partners LLC decreased its holdings in shares of TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) by 29.9% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 126,471 shares of the biDecember 4, 2024 | marketbeat.comCitigroup Inc. Increases Stake in TG Therapeutics, Inc. (NASDAQ:TGTX)Citigroup Inc. raised its stake in shares of TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) by 125.7% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 168,277 shares of the biopharmaceutical company's stockDecember 4, 2024 | marketbeat.comHunting For Magnificent Growth Next Year? Check Out These 7 Stocks.December 3, 2024 | investors.comPDT Partners LLC Invests $1.42 Million in TG Therapeutics, Inc. (NASDAQ:TGTX)PDT Partners LLC purchased a new position in shares of TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 60,669 shares of the biopharmaceutical company's stock, valuedDecember 2, 2024 | marketbeat.comPublic Sector Pension Investment Board Makes New Investment in TG Therapeutics, Inc. (NASDAQ:TGTX)Public Sector Pension Investment Board bought a new stake in TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 283,000 shares of theDecember 1, 2024 | marketbeat.comTG Therapeutics to Participate in the Evercore HealthCONx ConferenceNovember 29, 2024 | globenewswire.comIntech Investment Management LLC Makes New Investment in TG Therapeutics, Inc. (NASDAQ:TGTX)Intech Investment Management LLC acquired a new stake in TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 48,263 shares of the biopharmaceutical company's sNovember 28, 2024 | marketbeat.comThrivent Financial for Lutherans Takes Position in TG Therapeutics, Inc. (NASDAQ:TGTX)Thrivent Financial for Lutherans purchased a new stake in shares of TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 104,764 shares of the biopharmaceutical company's stock, valued at approxNovember 28, 2024 | marketbeat.comMutual of America Capital Management LLC Takes $469,000 Position in TG Therapeutics, Inc. (NASDAQ:TGTX)Mutual of America Capital Management LLC purchased a new position in shares of TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 20,064 shares of the biopharmaceuNovember 28, 2024 | marketbeat.comAlgert Global LLC Sells 42,966 Shares of TG Therapeutics, Inc. (NASDAQ:TGTX)Algert Global LLC decreased its stake in TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) by 29.2% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 104,252 shares of the biopharmaceutical company's stockNovember 27, 2024 | marketbeat.comTG Therapeutics price target raised to $43 from $30 at JPMorganNovember 26, 2024 | markets.businessinsider.comPenserra Capital Management LLC Raises Holdings in TG Therapeutics, Inc. (NASDAQ:TGTX)Penserra Capital Management LLC increased its position in TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) by 293.6% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 98,144 shares of the biopharmacNovember 26, 2024 | marketbeat.comTG Therapeutics (NASDAQ:TGTX) Hits New 12-Month High on Analyst UpgradeTG Therapeutics (NASDAQ:TGTX) Sets New 52-Week High Following Analyst UpgradeNovember 25, 2024 | marketbeat.comJPMorgan Chase & Co. Increases TG Therapeutics (NASDAQ:TGTX) Price Target to $43.00JPMorgan Chase & Co. increased their price target on TG Therapeutics from $30.00 to $43.00 and gave the company an "overweight" rating in a report on Monday.November 25, 2024 | marketbeat.comEagle Asset Management Inc. Invests $3.95 Million in TG Therapeutics, Inc. (NASDAQ:TGTX)Eagle Asset Management Inc. bought a new position in shares of TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 168,795 shares of the biopharmaceutical company's stock, valuedNovember 25, 2024 | marketbeat.comTG Therapeutics, Inc. (NASDAQ:TGTX) Given Average Recommendation of "Moderate Buy" by BrokeragesTG Therapeutics, Inc. (NASDAQ:TGTX - Get Free Report) has received a consensus rating of "Moderate Buy" from the six brokerages that are currently covering the company, Marketbeat reports. One equities research analyst has rated the stock with a hold rating and five have assigned a buy rating toNovember 25, 2024 | marketbeat.comSegall Bryant & Hamill LLC Makes New $1.23 Million Investment in TG Therapeutics, Inc. (NASDAQ:TGTX)Segall Bryant & Hamill LLC bought a new position in shares of TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 52,390 shares of the biopharmaceutical company'sNovember 24, 2024 | marketbeat.comTG Therapeutics Ranked Number One Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™November 21, 2024 | globenewswire.comOppenheimer & Co. Inc. Takes Position in TG Therapeutics, Inc. (NASDAQ:TGTX)Oppenheimer & Co. Inc. bought a new position in TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) in the third quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 32,470 shares of the biopharmaceutical company's stock, valued at approximately $759,000. A nuNovember 20, 2024 | marketbeat.comState of New Jersey Common Pension Fund D Decreases Holdings in TG Therapeutics, Inc. (NASDAQ:TGTX)State of New Jersey Common Pension Fund D lowered its stake in TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) by 27.2% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 82,752 shares of the biopharmaceutiNovember 18, 2024 | marketbeat.comEntropy Technologies LP Takes $730,000 Position in TG Therapeutics, Inc. (NASDAQ:TGTX)Entropy Technologies LP acquired a new position in TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund acquired 31,200 shares of the biopharmaceutical company's stock, valued aNovember 15, 2024 | marketbeat.comTG Therapeutics, Inc. (NASDAQ:TGTX) Stake Boosted by Principal Financial Group Inc.Principal Financial Group Inc. lifted its stake in shares of TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) by 1,549.4% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 772,188 shares of the biopharmaceutical company's stocNovember 15, 2024 | marketbeat.comAmalgamated Bank Has $925,000 Stake in TG Therapeutics, Inc. (NASDAQ:TGTX)Amalgamated Bank lifted its position in shares of TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) by 712.0% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 39,528 shares of the biopharmaceutical company's stock aftNovember 15, 2024 | marketbeat.comReporters tweets about ‘vague whispers’ of bid interest in TG TherapeuticsNovember 14, 2024 | markets.businessinsider.comTG Therapeutics, Inc. (NASDAQ:TGTX) Director Sells $152,200.00 in StockNovember 13, 2024 | insidertrades.comLos Angeles Capital Management LLC Has $2.89 Million Holdings in TG Therapeutics, Inc. (NASDAQ:TGTX)Los Angeles Capital Management LLC increased its position in TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) by 33.7% in the third quarter, according to its most recent 13F filing with the SEC. The firm owned 123,401 shares of the biopharmaceutical company's stock after purchasing an additional 3November 13, 2024 | marketbeat.comInsider Sale: Director Sagar Lonial Sells 5,000 Shares of TG Therapeutics Inc (TGTX)November 12, 2024 | gurufocus.comInsider Sale: Director Laurence Charney Sells 25,000 Shares of TG Therapeutics Inc (TGTX)November 12, 2024 | gurufocus.comNew York State Teachers Retirement System Purchases Shares of 42,927 TG Therapeutics, Inc. (NASDAQ:TGTX)New York State Teachers Retirement System acquired a new position in shares of TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) during the third quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 42,927 shares of the biopharmaceutical company's stock, vNovember 10, 2024 | marketbeat.comFY2024 EPS Estimate for TG Therapeutics Raised by AnalystTG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) - Cantor Fitzgerald raised their FY2024 earnings per share estimates for TG Therapeutics in a report released on Tuesday, November 5th. Cantor Fitzgerald analyst P. Agrawal now expects that the biopharmaceutical company will post earnings of $0.10November 8, 2024 | marketbeat.comTG Therapeutics (NASDAQ:TGTX) Hits New 12-Month High - Here's WhyTG Therapeutics (NASDAQ:TGTX) Reaches New 52-Week High - Should You Buy?November 7, 2024 | marketbeat.comTG Therapeutics, Inc. Just Missed Earnings - But Analysts Have Updated Their ModelsNovember 7, 2024 | finance.yahoo.comB. Riley Lowers Earnings Estimates for TG TherapeuticsTG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) - Equities researchers at B. Riley reduced their FY2027 EPS estimates for shares of TG Therapeutics in a research report issued on Monday, November 4th. B. Riley analyst M. Mamtani now anticipates that the biopharmaceutical company will earn $2.46November 7, 2024 | marketbeat.comHC Wainwright Forecasts TG Therapeutics FY2024 EarningsTG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) - Research analysts at HC Wainwright reduced their FY2024 earnings per share estimates for shares of TG Therapeutics in a report issued on Monday, November 4th. HC Wainwright analyst E. White now forecasts that the biopharmaceutical company will eNovember 7, 2024 | marketbeat.comQ3 2024 TG Therapeutics Inc Earnings CallNovember 6, 2024 | finance.yahoo.comTG Therapeutics Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS LagsNovember 6, 2024 | uk.finance.yahoo.com Get TG Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TGTX and its competitors with MarketBeat's FREE daily newsletter. Email Address How Low-Cost Stocks Generate Monthly Income (Ad)Are you ready to transform your investment strategy and generate a steady monthly income? We’re excited to offer you our exclusive report, "Options Trading Strategy: 2 (Surprisingly) Low-Cost Stocks Primed for Generating Monthly Income," FREE! 👉 Yes, I Want the Free Report! 👈 TGTX Media Mentions By Week TGTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TGTX News Sentiment▼1.310.61▲Average Medical News Sentiment TGTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TGTX Articles This Week▼56▲TGTX Articles Average Week Get TG Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TGTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Teva Pharmaceutical Industries News BeiGene News Moderna News Viatris News Summit Therapeutics News Genmab A/S News Dr. Reddy's Laboratories News Sarepta Therapeutics News Catalent News Vaxcyte News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TGTX) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TG Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TG Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TGTX Stock Alerts